Flora Corporation Fund Raise of ₹0.5 Cr

Flora Corporation Board Meeting Date

Flora Corporation Limited has scheduled a board meeting for October 22, 2026, to discuss potential fund-raising activities.

Flora Corporation Other Announcement

Flora Corporation Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.

Flora Corporation Annual General Meeting

Flora Corporation held its 38th Annual General Meeting on September 26, 2026, via video conferencing. The meeting covered routine business, including the adoption of financial statements.

Flora Corporation Annual Report

Flora Corporation Limited submitted its 38th Annual Report for the financial year 2025-26. The filing includes the notice for the upcoming Annual General Meeting.

Flora Corporation Annual General Meeting

Flora Corporation Limited has scheduled its 38th Annual General Meeting for September 26, 2026, and appointed a scrutinizer for the associated e-voting process.

Flora Corporation Q1 FY27 Results: Net Loss of ₹0.6 Cr, Loss Widens

Flora Corporation Ltd reported revenue from operations of ₹8.5 Cr (-35.6% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.

Key figure

Net loss ₹0.6 Cr

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.